• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载体蛋白的适度聚乙二醇化可提高A群脑膜炎球菌多糖结合疫苗的多糖特异性免疫原性。

Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine.

作者信息

Zhang Tingting, Yu Weili, Wang Yanfei, Hu Tao

机构信息

School of Chemistry and Chemical Engineering, University of South China, Hengyang 421001, Hunan Province, China; National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.

National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.

出版信息

Vaccine. 2015 Jun 22;33(28):3208-14. doi: 10.1016/j.vaccine.2015.04.094. Epub 2015 May 8.

DOI:10.1016/j.vaccine.2015.04.094
PMID:25964170
Abstract

Neisseria meningitidis can cause severe and fulminant diseases such as meningitis. Meningococcal capsular polysaccharide (PS) is a key virulence determinant that is not able to induce immunological memory. Conjugation of PS to a carrier protein can significantly increase the immunogenicity of PS and induce immunological memory. Due to the classically described carrier-induced epitopic suppression (CIES) mechanisms, a strong immune response against the carrier protein could suppress the immune response to PS after coadministration of free carrier protein with the conjugate vaccine. However, it was not clear whether suppressing or enhancing the protein-specific immunogenicity could improve the PS-specific immunogenicity of the conjugate vaccine. Thus, moderate PEGylation, extensive PEGylation and oligomerization were used to regulate the immunogenicity of tetanus toxoid (TT) in the conjugate vaccine (PS-TT). Moderate PEGylation led to a 2.7-fold increase in the PS-specific IgG titers elicited by PS-TT. In contrast, extensive PEGylation and oligomerization of TT led to 1.4-fold and 1.6-fold decrease in the PS-specific IgG titers elicited by PS-TT, respectively. The PS-specific immunogenicity of PS-TT can be increased by moderate PEGylation through mild suppression of the TT-specific immunogenicity. The PS-specific immunogenicity of PS-TT was decreased through significant suppression or enhancement of the TT-specific immunogenicity. Thus, our study contributes to understand the CIES mechanisms and improve the PS-specific immunogenicity of a meningococcal PS conjugate vaccine.

摘要

脑膜炎奈瑟菌可引起严重且暴发性的疾病,如脑膜炎。脑膜炎球菌荚膜多糖(PS)是一种关键的毒力决定因素,无法诱导免疫记忆。将PS与载体蛋白结合可显著提高PS的免疫原性并诱导免疫记忆。由于经典描述的载体诱导表位抑制(CIES)机制,在将游离载体蛋白与结合疫苗共同给药后,针对载体蛋白的强烈免疫反应可能会抑制对PS的免疫反应。然而,尚不清楚抑制或增强蛋白特异性免疫原性是否能提高结合疫苗的PS特异性免疫原性。因此,采用适度聚乙二醇化、广泛聚乙二醇化和寡聚化来调节结合疫苗(PS-TT)中破伤风类毒素(TT)的免疫原性。适度聚乙二醇化使PS-TT诱导的PS特异性IgG滴度增加了2.7倍。相比之下,TT的广泛聚乙二醇化和寡聚化分别使PS-TT诱导的PS特异性IgG滴度降低了1.4倍和1.6倍。通过适度抑制TT特异性免疫原性,适度聚乙二醇化可提高PS-TT的PS特异性免疫原性。通过显著抑制或增强TT特异性免疫原性,PS-TT的PS特异性免疫原性会降低。因此,我们的研究有助于理解CIES机制并提高脑膜炎球菌PS结合疫苗的PS特异性免疫原性。

相似文献

1
Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine.载体蛋白的适度聚乙二醇化可提高A群脑膜炎球菌多糖结合疫苗的多糖特异性免疫原性。
Vaccine. 2015 Jun 22;33(28):3208-14. doi: 10.1016/j.vaccine.2015.04.094. Epub 2015 May 8.
2
PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine.PEG 作为间隔臂显著增加了脑膜炎球菌 Y 多糖结合疫苗的免疫原性。
J Control Release. 2013 Nov 28;172(1):382-389. doi: 10.1016/j.jconrel.2013.03.008. Epub 2013 Mar 17.
3
Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine.β-葡聚糖的结合显著提高了Y群脑膜炎球菌多糖结合疫苗的免疫原性。
Vaccine. 2015 Apr 21;33(17):2066-72. doi: 10.1016/j.vaccine.2015.02.045. Epub 2015 Feb 27.
4
New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.新型脑膜炎球菌C多糖-破伤风类毒素结合物:理化及免疫学特性
Vaccine. 2007 Feb 26;25(10):1798-805. doi: 10.1016/j.vaccine.2006.11.029. Epub 2006 Dec 5.
5
Molecular shape and immunogenicity of meningococcal polysaccharide group A conjugate vaccine.A群脑膜炎球菌结合疫苗的分子形状与免疫原性
Vaccine. 2015 Oct 26;33(43):5815-5821. doi: 10.1016/j.vaccine.2015.09.021. Epub 2015 Sep 19.
6
The phenyl linker markedly increases the immunogenicity of the pneumococcal polysaccharide conjugate vaccine.苯基连接子显著提高了肺炎球菌多糖结合疫苗的免疫原性。
Biotechnol Lett. 2018 Aug;40(8):1263-1270. doi: 10.1007/s10529-018-2575-7. Epub 2018 May 25.
7
Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM, DT and TT glycoconjugate vaccines.A、C、W、Y群脑膜炎球菌-CRM、DT和TT糖共轭疫苗的质量、免疫原性及稳定性
Vaccine. 2017 Jun 16;35(28):3598-3606. doi: 10.1016/j.vaccine.2017.03.066. Epub 2017 Apr 10.
8
Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.通过高碘酸盐活化O-乙酰化、非O-乙酰化和化学去O-乙酰化多糖制备的脑膜炎奈瑟菌W135群多糖-破伤风类毒素结合疫苗的比较
Vaccine. 2007 Nov 14;25(46):7972-80. doi: 10.1016/j.vaccine.2007.06.018. Epub 2007 Jun 29.
9
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.在非洲人中,脑膜炎球菌 A 结合疫苗的免疫原性和安全性。
N Engl J Med. 2011 Jun 16;364(24):2293-304. doi: 10.1056/NEJMoa1003812.
10
The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine.四价脑膜炎球菌血清型 A、C、W-135 和 Y 破伤风类毒素结合疫苗在先前接种过四价多糖疫苗的受试者中具有免疫原性,且临床安全性可接受。
Int J Infect Dis. 2012 Aug;16(8):e608-15. doi: 10.1016/j.ijid.2012.04.006. Epub 2012 Jun 14.

引用本文的文献

1
Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice.破伤风类毒素的既有免疫力对破伤风类毒素结合海洛因疫苗在小鼠中疗效的影响。
Vaccines (Basel). 2021 Jun 1;9(6):573. doi: 10.3390/vaccines9060573.
2
Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.颠覆传统:聚合物纳米颗粒链接疫苗直击呼吸道病毒
Life Sci. 2021 Sep 1;280:119744. doi: 10.1016/j.lfs.2021.119744. Epub 2021 Jun 24.
3
The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity.
肺炎球菌多糖-破伤风类毒素天然 C 片段缀合疫苗:载体效应和免疫原性。
Mediators Inflamm. 2020 Jul 4;2020:9596129. doi: 10.1155/2020/9596129. eCollection 2020.
4
Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy.抗原结构和组成设计以提高基于蛋白质的疫苗效力。
Front Immunol. 2020 Feb 24;11:283. doi: 10.3389/fimmu.2020.00283. eCollection 2020.